Literature DB >> 1580901

Vibrio vulnificus infection and iron overload.

C A Kraffert, D J Hogan.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1580901     DOI： 10.1016/s0190-9622(08)80542-7

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  6 in total

1.  Monoclonal antibodies against Vibrio vulnificus RtxA1 elicit protective immunity through distinct mechanisms.

Authors:  Tae Hee Lee; Sun-Shin Cha; Chang-Seop Lee; Joon Haeng Rhee; Kyung Min Chung
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

2.  Pathogenesis of infection by clinical and environmental strains of Vibrio vulnificus in iron-dextran-treated mice.

Authors:  A M Starks; T R Schoeb; M L Tamplin; S Parveen; T J Doyle; P E Bomeisl; G M Escudero; P A Gulig
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

3.  The pyrH gene of Vibrio vulnificus is an essential in vivo survival factor.

Authors:  Shee Eun Lee; Soo Young Kim; Choon Mee Kim; Mi-Kwang Kim; Young Ran Kim; Kwangjoon Jeong; Hwa-Ja Ryu; Youn Suhk Lee; Sun Sik Chung; Hyon E Choy; Joon Haeng Rhee
Journal:  Infect Immun       Date:  2007-03-19       Impact factor: 3.441

4.  Genotype is correlated with but does not predict virulence of Vibrio vulnificus biotype 1 in subcutaneously inoculated, iron dextran-treated mice.

Authors:  Patrick C Thiaville; Keri L Bourdage; Anita C Wright; Melissa Farrell-Evans; Cynthia Wilson Garvan; Paul A Gulig
Journal:  Infect Immun       Date:  2011-01-03       Impact factor: 3.441

5.  Phage therapy of local and systemic disease caused by Vibrio vulnificus in iron-dextran-treated mice.

Authors:  Karen E Cerveny; Angelo DePaola; Donna H Duckworth; Paul A Gulig
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

6.  Vibrio vulnificus damages macrophages during the early phase of infection.

Authors:  Takahiro Tsuchiya; Eriko Mitsuo; Nahoko Hayashi; Yuuko Hikita; Hiroshi Nakao; Shigeo Yamamoto; Katsushiro Miyamoto; Hiroshi Tsujibo
Journal:  Infect Immun       Date:  2007-06-25       Impact factor: 3.441
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.